GLP-1 Drugs Like Ozempic Might Cut Cancer Risk Too, Study FindsObesity treatment drugs show potential anticancer effects, proving 41% more effective than surgery in preventing obesity-related cancers.
Wegovy or Wait? New Pills Could Reshape the Weight Loss Treatment LandscapeThe obesity treatment market is shifting with new oral medications emerging, offering alternatives to injectable options.
Eli Lilly Moves First in India, Beats Novo in Obesity Drug ShowdownEli Lilly launches Mounjaro in India, targeting a large market and competing with Novo Nordisk's Wegovy for obesity treatment.
Must-Reads
1
Trump Claims Epstein 'Stole' Young Women from Mar-a-Lago Spa
LATEST
2
Say Hello to Your New Beauty Buddy: AI-Powered Kiosks Hit GS25 Stores!
LATEST
3
New Task Force Takes Aim at Stock Manipulators: A Game Changer for Investors!
LATEST
4
COP30 Chaos: Will Brazil's Soaring Hotel Prices Keep Poor Nations Out of Climate Talks?
LATEST
5
Is Tesla Behind LG Energy's Massive Battery Supply Contract?
GLP-1 Drugs Like Ozempic Might Cut Cancer Risk Too, Study Finds Obesity treatment drugs show potential anticancer effects, proving 41% more effective than surgery in preventing obesity-related cancers.
Wegovy or Wait? New Pills Could Reshape the Weight Loss Treatment Landscape The obesity treatment market is shifting with new oral medications emerging, offering alternatives to injectable options.
Eli Lilly Moves First in India, Beats Novo in Obesity Drug Showdown Eli Lilly launches Mounjaro in India, targeting a large market and competing with Novo Nordisk's Wegovy for obesity treatment.
Hot Topics